التفاصيل البيبلوغرافية
| العنوان: |
BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). |
| المؤلفون: |
Cornillon, Jérôme, Daguenet, Elisabeth, Bay, Jacques-Olivier, Chauchet, Adrien, Salles, Gilles, Contentin, Nathalie, Nicolas-Virelizier, Emmanuelle, Mercier, Mélanie, Vallet, Nicolas, Alexis, Magda, Chrétien, Marie-Lorraine, Cluzeau, Thomas, Huynh, Anne, Himberlin, Chantal, Dorvaux, Véronique, Amorim, Sandy, Lejeune, Caroline, de Latour, Régis Peffault, Gyan, Emmanuel |
| المصدر: |
Annals of Hematology; Aug2019, Vol. 98 Issue 8, p1973-1980, 8p |
| مصطلحات موضوعية: |
BONE marrow transplantation, CELL transplantation, AUTOTRANSPLANTATION, CELLULAR therapy, PROGRESSION-free survival, LYMPHOMA diagnosis, LYMPHOMA treatment, AGE distribution, ANTINEOPLASTIC agents, AUTOGRAFTS, IMMUNOSUPPRESSION, LYMPHOMAS, MULTIVARIATE analysis, PROGNOSIS, SURVIVAL analysis (Biometry), RETROSPECTIVE studies, CYTARABINE, MELPHALAN, BUSULFAN, MUCOSITIS |
| مصطلحات جغرافية: |
FRANCE |
| مستخلص: |
High-dose chemotherapy before autologous transplantation is a therapeutic option as consolidation in primary or relapsed lymphoma. Even if BEAM conditioning is generally used, alternative conditioning regimens have been published. The purpose of this study was to assess the outcome of 177 adult patients with lymphoma whose conditioning treatment included a BAM (busulfan, aracytine, and melphalan) regimen. With a median follow-up of 17.4 months, 2-year estimates of overall survival and progression-free survival for the entire group were 87% and 70.5%, respectively. Mucositis was the main reported complications and infectious episodes were described in 80.2% of patients. According to multivariate analysis, high performance status and age at diagnosis were adverse factors for survival and increased the risk of disease relapse and death. Despite its limitations, this retrospective study suggests that BAM combination is a valid conditioning regimen in lymphoma patients, with an acceptable rate of toxicity. [ABSTRACT FROM AUTHOR] |
|
Copyright of Annals of Hematology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
